Sotrovimab (VIR 7831) is a monoclonal antibody against the SARS-CoV-2 virus that causes COVID-19. It has antiviral activity, induces serum neutralization of BQ.1 and antibody-dependent cytotoxicity, and may be used to study viral infections.
Purity:
98.50%
CAS Number:
[2423014-07-5]
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted